SCF Ubiquitin Ligases in Cell Cycle Control and Chromosome Stability
SCF 泛素连接在细胞周期控制和染色体稳定性中的作用
基本信息
- 批准号:10599187
- 负责人:
- 金额:$ 31.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisApoptosisAttentionBindingCRISPR/Cas technologyCell CycleCell Cycle ProgressionCell Cycle RegulationCell LineCellsCementationChromosomal StabilityClinicalComplexCyclin-Dependent Kinase InhibitorCyclin-Dependent KinasesCyclinsDataDeubiquitinationDiseaseEnzymesEukaryotaF Box DomainF-Box ProteinsFamilyFundingGene ExpressionGenesGenetic TranscriptionGoalsGrowthHealthHumanHuman Cell LineImpairmentKineticsKnowledgeLigaseLinkMalignant NeoplasmsMass Spectrum AnalysisMessenger RNAMethodologyMusMutationNamesNeurodegenerative DisordersNormal CellPLK1 genePathway interactionsPhenotypePhosphoproteinsPhosphorylationPhosphorylation SitePhosphotransferasesPlayPost-Translational RegulationProcessProliferatingProtein FamilyProteinsProteomeProteomicsRBL2 geneRegulationResourcesRetinoblastomaRoleS phaseSystemTextbooksTumor Suppressor ProteinsUbiquitinUbiquitin familyUbiquitinationWorkcdc Genescyclin Fgenome integritygenome-widehuman diseasein silicoinnovationloss of functionmembernervous system disorderovarian neoplasmoverexpressionprogramsprotein degradationreceptorretinoblastoma pathwaysenescenceubiquitin isopeptidaseubiquitin ligaseubiquitin-protein ligase
项目摘要
PROJECT SUMMARY ABSTRACT
Dynamic oscillations in the abundance and activity of key proteins drives cell cycle progression. This is typified
by cyclins and cyclin kinase inhibitors (CKIs), which oscillate during cell cycle progression and determine the
activation kinetics of Cyclin Dependent Kinases, which propel the cell cycle forward. Defining the pathways,
networks and mechanisms underlying dynamics in protein abundance during normal cell cycles is essential to
understanding proliferative control. Ubiquitin is the major regulator of protein degradation in eukaryotes and
plays an essential and highly conserved role in cell cycle progression. The Skp1-Cul1-F-box (SCF) family of E3
ubiquitin ligases are major regulators of cell cycle progression and sculpt the protein landscape post-
translationally to facilitate proliferation. SCF ligases engage a set of ~70 interchangeable substrate receptors
termed F-box proteins, which dictate SCF target selection. The eponymous Cyclin F is the founding member of
the F-box family and has a cyclin homology domain like that found in the canonical CDK activators. Rather
than activate a CDK to promote cell cycle via phosphorylation, cyclin F binds to the SCF, promoting cell cycle
through ubiquitination. Cyclin F mRNA and protein levels oscillate significantly during the cell cycle and to a
greater extent than other F-box encoding genes. Cyclin F is required for viability in mice and essential for
growth/survival in many human cell lines. Further, it is overexpressed in cancer, and its mutation is linked to
the neurodegenerative disease amyotrophic lateral sclerosis. Nevertheless, there remain significant knowledge
gaps related to what pathways cyclin F controls and how it is regulated. Defining substrates and mechanisms
of cyclin F is significant to a fundamental understanding of cell cycle, as well as human health. During the
previous funding cycle, our lab identified several cyclin F substrates, highlighting its importance in cell cycle
control. Here, we build on that work, defining a new substrate with important roles in normal cell cycle control
and with relevance to disease, while also beginning to dissect the complex mechanisms by which cyclin F is
controlled. Borne out of innovative, unbiased, computational, and proteomic strategies, our data suggest new,
critical roles for cyclin F in cell cycle, and undescribed mechanisms underlying its regulation. In aim 1, we
examine the role of cyclin F in G1/S progression through regulation of a tumor suppressor in the
retinoblastoma (RB)-pocket protein family, RBL2/p130. We will determine the mechanisms by which cyclin F
controls the RB-pathway and how this contributes to gene expression, cell cycle, and proliferative control. In
aims 2 and 3, we turn our attention towards mechanisms that converge on cyclin F to regulate its abundance
and potentially activity. Aim 2 is focused on the regulation of cyclin F by kinases and how they determine cyclin
F stability. In aim 3 we extend this analysis of post-translational regulation of cyclin F, determining how it is
regulated by deubiquitinases. Together, these studies will provide a comprehensive analysis for how cyclin F is
itself regulated and its contributions to cell cycle in humans.
项目摘要
关键蛋白质丰度和活性的动态振荡驱动细胞周期进程。这是典型的
细胞周期蛋白和细胞周期蛋白激酶抑制剂(CKIs),它们在细胞周期进程中振荡,并决定细胞周期。
细胞周期蛋白依赖性激酶的激活动力学,其推动细胞周期向前。定义路径,
在正常细胞周期中蛋白质丰度动态的网络和机制对于
了解增殖控制。泛素是真核生物中蛋白质降解的主要调节因子,
在细胞周期进程中起重要和高度保守的作用。E3的Skp 1-Cul 1-F-box(SCF)家族
泛素连接酶是细胞周期进程的主要调节因子,
以促进扩散。SCF连接酶与一组约70种可互换的底物受体结合
称为F-box蛋白,其决定SCF靶选择。Epoxy Cyclin F是细胞周期蛋白的创始成员,
F-box家族,并具有与典型CDK激活剂中发现的类似的细胞周期蛋白同源结构域。而
除了通过磷酸化激活CDK以促进细胞周期外,细胞周期蛋白F与SCF结合,促进细胞周期
通过泛素化。细胞周期蛋白F mRNA和蛋白水平在细胞周期中显著振荡,
比其他F-box编码基因更大的程度。细胞周期蛋白F是小鼠生存所必需的,
在许多人类细胞系中的生长/存活。此外,它在癌症中过度表达,其突变与癌症相关。
神经变性疾病肌萎缩性侧索硬化症然而,仍然有大量的知识
与细胞周期蛋白F控制什么途径以及如何调节有关的空白。定义基质和机制
对细胞周期蛋白F的研究对于细胞周期的基本认识以及人类健康都具有重要意义。期间
在上一个资助周期中,我们的实验室鉴定了几种细胞周期蛋白F底物,突出了其在细胞周期中的重要性
控制在这里,我们建立在这项工作的基础上,定义了一种在正常细胞周期控制中具有重要作用的新底物
并与疾病相关,同时也开始剖析细胞周期蛋白F的复杂机制,
控制。基于创新的、无偏见的、计算的和蛋白质组学的策略,我们的数据表明,
细胞周期蛋白F在细胞周期中的关键作用,以及其调节的未描述机制。在目标1中,我们
研究细胞周期蛋白F在G1/S进程中的作用,通过调节肿瘤抑制因子,
视网膜母细胞瘤(RB)-口袋蛋白家族,RBL 2/p130。我们将确定细胞周期蛋白F
控制RB通路以及这如何有助于基因表达、细胞周期和增殖控制。在
目标2和3,我们把我们的注意力集中在细胞周期蛋白F的机制,以调节其丰度
潜在的活动。目的2是研究激酶对细胞周期蛋白F的调控及其如何决定细胞周期蛋白的表达。
F稳定性。在目标3中,我们扩展了对细胞周期蛋白F的翻译后调节的分析,确定它是如何被调节的。
由去泛素化酶调节。总之,这些研究将提供一个全面的分析,如何细胞周期蛋白F是
自身调节及其对人类细胞周期的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael James Emanuele其他文献
Michael James Emanuele的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael James Emanuele', 18)}}的其他基金
Predoctoral Training in the Pharmacological Sciences
药理学博士前培训
- 批准号:
10405531 - 财政年份:2020
- 资助金额:
$ 31.44万 - 项目类别:
SCF Ubiquitin Ligases in Cell Cycle Control and Chromosome Stability
SCF 泛素连接在细胞周期控制和染色体稳定性中的作用
- 批准号:
10365189 - 财政年份:2016
- 资助金额:
$ 31.44万 - 项目类别:
SCF Ubiquitin Ligases in Cell Cycle Control and Chromosome Stability
SCF 泛素连接在细胞周期控制和染色体稳定性中的作用
- 批准号:
9158827 - 财政年份:2016
- 资助金额:
$ 31.44万 - 项目类别:
SCF Ubiquitin Ligases in Cell Cycle Control and Chromosome Stability
SCF 泛素连接在细胞周期控制和染色体稳定性中的作用
- 批准号:
10795142 - 财政年份:2016
- 资助金额:
$ 31.44万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 31.44万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 31.44万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 31.44万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 31.44万 - 项目类别:
Fellowship